← Every company
BridgeBio Pharma Inc SEC Filings
What BridgeBio Pharma Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
BBIO overview →Filings on file
111
since May 24, 2019
Warning signs
0
none filed
Last results
Aug 10, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 17, 2026 | Material agreement 8-K | Read ↗ |
| Aug 10, 2026 | Quarterly report 10-Q | Read ↗ |
| Aug 10, 2026 | Results announced 8-K | Read ↗ |
| Jul 2, 2026 | Material agreementUnregistered share sale 8-K | Read ↗ |
| Jun 26, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 8, 2026 | Material agreement 8-K | Read ↗ |
| May 7, 2026 | Quarterly report 10-Q | Read ↗ |
| May 7, 2026 | Results announced 8-K | Read ↗ |
| Feb 24, 2026 | Annual report 10-K | Read ↗ |
| Feb 24, 2026 | Results announced 8-K | Read ↗ |
| Jan 21, 2026 | Material agreementNew debtUnregistered share sale 8-K | Read ↗ |
| Jan 12, 2026 | Results announced 8-K | Read ↗ |
| Oct 29, 2025 | Quarterly report 10-Q | Read ↗ |
| Oct 29, 2025 | Results announced 8-K | Read ↗ |
| Aug 5, 2025 | Quarterly report 10-Q | Read ↗ |
| Aug 5, 2025 | Results announced 8-K | Read ↗ |
| Jul 2, 2025 | Material agreementNew debt 8-K | Read ↗ |
| Jun 23, 2025 | Shareholder vote 8-K | Read ↗ |
| Apr 29, 2025 | Quarterly report 10-Q | Read ↗ |
| Apr 29, 2025 | Results announced 8-K | Read ↗ |
| Mar 17, 2025 | Executive or director change 8-K | Read ↗ |
| Feb 28, 2025 | Material agreementNew debtUnregistered share sale 8-K | Read ↗ |
| Feb 20, 2025 | Annual report 10-K | Read ↗ |
| Feb 20, 2025 | Results announced 8-K | Read ↗ |
| Jan 13, 2025 | Results announced 8-K | Read ↗ |
| Nov 12, 2024 | Quarterly report 10-Q | Read ↗ |
| Nov 12, 2024 | Results announced 8-K | Read ↗ |
| Aug 21, 2024 | Material agreement 8-K | Read ↗ |
| Aug 1, 2024 | Quarterly report 10-Q | Read ↗ |
| Aug 1, 2024 | Results announced 8-K | Read ↗ |
| Jul 23, 2024 | Executive or director change 8-K | Read ↗ |
| Jun 24, 2024 | Shareholder vote 8-K | Read ↗ |
| May 2, 2024 | Quarterly report 10-Q | Read ↗ |
| May 2, 2024 | Results announced 8-K | Read ↗ |
| Mar 6, 2024 | Material agreement 8-K | Read ↗ |
| Mar 4, 2024 | Material agreement 8-K | Read ↗ |
| Feb 22, 2024 | Annual report 10-K | Read ↗ |
| Feb 22, 2024 | Results announced 8-K | Read ↗ |
| Jan 18, 2024 | Material agreementNew debt 8-K | Read ↗ |
| Nov 2, 2023 | Quarterly report 10-Q | Read ↗ |
| Nov 2, 2023 | Results announced 8-K | Read ↗ |
| Sep 25, 2023 | Material agreementUnregistered share sale 8-K | Read ↗ |
| Aug 3, 2023 | Quarterly report 10-Q | Read ↗ |
| Aug 3, 2023 | Results announced 8-K | Read ↗ |
| Jun 22, 2023 | Shareholder vote 8-K | Read ↗ |
| May 4, 2023 | Material agreement 8-K | Read ↗ |
| May 4, 2023 | Quarterly report 10-Q | Read ↗ |
| May 4, 2023 | Results announced 8-K | Read ↗ |
| Mar 9, 2023 | Material agreement 8-K | Read ↗ |
| Feb 23, 2023 | Annual report 10-K | Read ↗ |
| Feb 23, 2023 | Executive or director changeResults announced 8-K | Read ↗ |
| Dec 6, 2022 | Material agreementNew debt 8-K | Read ↗ |
| Nov 3, 2022 | Results announced 8-K | Read ↗ |
| Nov 3, 2022 | Quarterly report 10-Q | Read ↗ |
| Aug 4, 2022 | Quarterly report 10-Q | Read ↗ |
| Aug 4, 2022 | Results announced 8-K | Read ↗ |
| Jun 24, 2022 | Shareholder vote 8-K | Read ↗ |
| May 18, 2022 | Material agreementNew debt 8-K | Read ↗ |
| May 13, 2022 | Material agreement 8-K | Read ↗ |
| May 10, 2022 | Results announced 8-K | Read ↗ |
| May 5, 2022 | Quarterly report 10-Q | Read ↗ |
| Feb 25, 2022 | Annual report 10-K | Read ↗ |
| Feb 24, 2022 | Results announced 8-K | Read ↗ |
| Dec 16, 2021 | Shareholder vote 8-K | Read ↗ |
| Nov 18, 2021 | Material agreementNew debt 8-K | Read ↗ |
| Nov 4, 2021 | Quarterly report 10-Q | Read ↗ |
| Nov 4, 2021 | Results announced 8-K | Read ↗ |
| Oct 26, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 23, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 13, 2021 | Results announced 8-K | Read ↗ |
| Aug 5, 2021 | Quarterly report 10-Q | Read ↗ |
| Jun 22, 2021 | Shareholder vote 8-K | Read ↗ |
| May 14, 2021 | Results announced 8-K | Read ↗ |
| May 6, 2021 | Quarterly report 10-Q | Read ↗ |
| Apr 15, 2021 | Material agreementNew debt 8-K | Read ↗ |
| Feb 26, 2021 | Results announced 8-K | Read ↗ |
| Feb 25, 2021 | Annual report 10-K | Read ↗ |
| Feb 17, 2021 | Material agreement 8-K | Read ↗ |
| Jan 29, 2021 | Material agreementNew debtUnregistered share sale 8-K | Read ↗ |
| Jan 26, 2021 | Material agreementNew debt 8-K | Read ↗ |
| Jan 26, 2021 | Acquisition or sale completed 8-K | Read ↗ |
| Jan 20, 2021 | Shareholder vote 8-K | Read ↗ |
| Jan 4, 2021 | Executive or director change 8-K | Read ↗ |
| Dec 15, 2020 | Merger vote or registration DEFM14A | Read ↗ |
| Nov 6, 2020 | Merger vote or registration S-4 | Read ↗ |
| Nov 5, 2020 | Quarterly report 10-Q | Read ↗ |
| Nov 5, 2020 | Results announced 8-K | Read ↗ |
| Oct 23, 2020 | Executive or director change 8-K | Read ↗ |
| Oct 6, 2020 | Material agreement 8-K | Read ↗ |
| Aug 11, 2020 | Quarterly report 10-Q | Read ↗ |
| Aug 11, 2020 | Results announced 8-K | Read ↗ |
| Jun 24, 2020 | Executive or director change 8-K | Read ↗ |
| Jun 8, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 14, 2020 | Quarterly report 10-Q | Read ↗ |
| May 13, 2020 | Results announced 8-K | Read ↗ |
| Apr 29, 2020 | Material agreementNew debt 8-K | Read ↗ |
| Mar 10, 2020 | Material agreementNew debtUnregistered share sale 8-K | Read ↗ |
| Mar 6, 2020 | Material agreementNew debt 8-K | Read ↗ |
| Mar 3, 2020 | Annual report 10-K | Read ↗ |
| Mar 2, 2020 | Results announced 8-K | Read ↗ |
| Feb 19, 2020 | Executive or director change 8-K | Read ↗ |
| Jan 7, 2020 | Material agreement 8-K | Read ↗ |
| Dec 26, 2019 | Results announced 8-K | Read ↗ |
| Dec 17, 2019 | Executive or director change 8-K | Read ↗ |
| Nov 19, 2019 | Material agreement 8-K | Read ↗ |
| Nov 8, 2019 | Quarterly report 10-Q | Read ↗ |
| Oct 11, 2019 | Executive or director change 8-K | Read ↗ |
| Sep 12, 2019 | Material agreement 8-K | Read ↗ |
| Aug 14, 2019 | Quarterly report 10-Q | Read ↗ |
| Jun 28, 2019 | Share offering 424B4 | Read ↗ |
| May 24, 2019 | Share offering S-1 | Read ↗ |
Source: BridgeBio Pharma Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on BBIO
Company overviewEverything on BBIO in one place, with the price.Insider tradingWhat BBIO's own officers and directors buy and sell.Executive payWhat BBIO awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in BBIO.Funds holding itWhich funds and ETFs hold BBIO, and how big a bet.LobbyingWhat BBIO spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on BBIO's account, and who they worked for.